innoscripta SE, a provider of SaaS solutions for R&D management, has launched operations in the United Kingdom, marking its second major European expansion following its entry into France earlier this year. The company has established a dedicated UK sales team and secured its first customer, a software firm with annual revenues in the mid-double-digit million euro range.
The customer has chosen innoscripta's platform, Clusterix, which has been adapted to meet UK regulatory requirements, to support its R&D tax relief claims. Clusterix allows companies to systematically track R&D projects, working hours, and eligible costs, creating a comprehensive audit trail. This capability is increasingly critical as HM Revenue & Customs has tightened documentation and compliance standards for R&D tax relief in recent years.
The UK represents a significant opportunity for innoscripta, as it is Europe's second-largest R&D tax incentive market after France, with annual tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP). This market is roughly seven times larger than Germany's, where innoscripta is headquartered. The company plans to expand its UK sales organization and customer base further by the end of the year, with several additional customer engagements already at advanced stages of negotiation.
innoscripta's expansion into the UK follows its successful market entry into France, announced on April 15, 2026. The company's international growth strategy leverages its scalable software platform, which helps businesses digitize and streamline R&D processes. By providing tools for innovation project management and cost tracking, Clusterix enables companies to make their R&D activities transparent and scalable, while also ensuring compliance with tax authorities.
The news underscores the growing importance of R&D tax incentives as a driver of innovation in Europe. With the UK and France leading in R&D tax relief spending, companies are increasingly seeking specialized software to manage claims efficiently and reduce the risk of non-compliance. innoscripta's Clusterix platform addresses this need, and its expansion into key markets positions it to capture a share of this growing demand.
For more information, see the original release at NewMediaWire.
